Glenn Pierce
Director · Voyager Therapeutics, Inc.
Individual
- 2025
- Jun 11, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Glenn Pierce files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alfred Sandrock - $184K in VYGR purchases and sales in the last 12 months
- Robin Swartz - $55K in VYGR purchases and sales in the last 12 months
- Todd Alfred Carter - $41K in VYGR purchases and sales in the last 12 months
- Nathan D. Jorgensen - $18K in VYGR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Glenn Pierce?
Glenn Pierce is a corporate insider, tracked as Director of Voyager Therapeutics, Inc. (VYGR). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Glenn Pierce last file a Form 4?
The most recent primary Form 4 on record is dated 11 June 2026, one of 2 filings going back to 2025.